Contract Manufacturing News
-
Samsung Biologics to launch new platforms for antibody development process
Contract Manufacturing | News | 0 Comment | 30 Sep, 2022
South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...Read more
-
Biosyngen boosts cell therapy GMP capabilities in Singapore
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...Read more
-
WuXi STA opens first high potency oral drug product manufacturing facility
Contract Manufacturing | News | 0 Comment | 28 Sep, 2022
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...Read more
-
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan
Contract Manufacturing | News | 0 Comment | 26 Sep, 2022
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...Read more
-
Hong Kong-based startup Great Bay Bio secures $15M funding
Contract Manufacturing | News | 0 Comment | 15 Sep, 2022
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...Read more
-
Catalent invests $2.2M for Singapore clinical supply facility expansion
Contract Manufacturing | News | 0 Comment | 07 Sep, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...Read more
-
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...Read more
-
WuXi Biologics opens first North American biomanufacturing facility in New Jersey
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...Read more
-
WuXi announces licensing agreement with Janssen for TESSA technology
Contract Manufacturing | News | 0 Comment | 12 Aug, 2022
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...Read more
-
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China
Contract Manufacturing | News | 0 Comment | 08 Aug, 2022
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...Read more
-
How CDMOs are Adapting to New mRNA Tech Demands
Contract Manufacturing | Opinion | By Ayesha Siddiqui | 0 Comment | 30 Jul, 2022
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...Read more
-
WuXi Biologics invests $1.4 B to build comprehensive CRDMO centre in Singapore
Contract Manufacturing | News | 0 Comment | 19 Jul, 2022
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...Read more
-
Samsung Biologics further invests KRW 426 B for Bio Campus 2
Contract Manufacturing | News | 0 Comment | 18 Jul, 2022
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...Read more
-
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan
Contract Manufacturing | News | 0 Comment | 15 Jul, 2022
TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...Read more
-
GenScript ProBio partners with DAAN Bio Therapeutics for novel drug discovery
Contract Manufacturing | News | 0 Comment | 14 Jul, 2022
GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...Read more
-
Amaran Biotech introduces first fully-automated robotic aseptic filling line in Taiwan
Contract Manufacturing | News | 0 Comment | 13 Jul, 2022
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., has completed the construction of it...Read more
-
WuXi STA opens new large-scale oligonucleotide and peptide manufacturing facility
Contract Manufacturing | News | 0 Comment | 07 Jul, 2022
WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...Read more
-
Vetter’s newest clinical manufacturing site successfully completed its first customer fills
Contract Manufacturing | News | 0 Comment | 04 Jul, 2022
Next milestone for the site development is achieved Positive feedback recei...Read more
